| 42.54 BATS BZX Real-Time Price As of 1:04pm ET |  +0.07 / +0.16%Today’s Change | 38.97 Today|||52-Week Range 45.62 | -2.00% Year-to-Date |
| Previous close | 42.47 |
| Today’s open | 42.47 |
| Day’s range | 42.34 - 42.68 |
| Volume | 2,765,827 |
| Average volume (3 months) | 1,231,988 |
| Market cap | $105.9B |
| Earnings growth (last year) | +19.94% |
| Earnings growth (this year) | +3.66% |
| Earnings growth (next 5 years) | +7.42% |
| Revenue growth (last year) | +2.83% |
| P/E ratio | 22.0 |
| Price/Sales | 2.68 |
| Price/Book | 1.57 |
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | +0.24 | +0.60% |
| LLYEli Lilly and Co | +0.62 | +0.55% |
| GSKGlaxoSmithKline | -0.15 | -0.37% |
| ABBVAbbVie | +0.18 | +0.23% |
| Next reporting date | July 29, 2019 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $40.7B |
| Annual profit (last year) | $5.1B |
| Net profit margin | 12.53% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Director Olivier Brandicourt |
Chief Financial Officer & Executive Vice President Jean-Baptiste Chasseloup de Chatillon |
Corporate headquarters Paris, Ile-de-france |
